Ciclesonide versus other inhaled steroids for chronic asthma in ...

The results of this review give some support to ciclesonide as an equivalent therapy to other ICS at similar nominal doses.

Ciclesonide versus other inhaled corticosteroids for chronic asthma ...

Ciclesonide compared to budesonide (dose ratio 1:2): asthma symptoms and adverse effect were similar in both groups. Pooled results showed no ...

Ciclesonide versus other inhaled corticosteroids for chronic asthma ...

Vermeulen JH, Minic P, Barkai L, Sreckovic MD, Gyurkovitis K, Rauer H, et al. Ciclesonide 320 mcg once daily is as effective as budesonide 800 mcg once daily ...

This study shows that inhaled ciclesonide (800 μg twice daily) has comparable efficacy to oral prednisolone (40 mg once daily) to regain asthma control.

Inhaled ciclesonide versus inhaled budesonide ... - BMC Primary Care

Ciclesonide is a new inhaled corticosteroids licensed for the prophylactic treatment of persistent asthma in adults.

Treatment of asthma by the inhaled corticosteroid ciclesonide given ...

Morning and evening administration was shown to be equally effective for the different spirometry variables, evening PEF, symptoms, use of rescue medication and ...

Ciclesonide versus other inhaled corticosteroids for chronic asthma ...

Kramer S, Rottier BL, Scholten RJPM, Boluyt N. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children. Cochrane Database of Systematic ...

Ciclesonide is more effective than budesonide in the treatment of ...

Ciclesonide is a lung-activated inhaled corticosteroid that provides effective control of persistent asthma. The objective of this study was to compare the ...

Comparison of the efficacy of ciclesonide with that of budesonide in ...

Inhaled corticosteroids (ICSs) are widely used in asthma control. Ciclesonide (CIC) is an ICS with on-site lung activation for potent ...

Ciclesonide versus other inhaled steroids for chronic asthma in ...

Equal daily doses of ciclesonide and beclomethasone (BDP) or budesonide (BUD) gave similar results for peak expiratory flow rates (PEF), although forced vital ...

Ciclesonide versus other inhaled corticosteroids for chronic asthma ...

Conclusion This study provides evidence that FF can provide more protection against airway hyperresponsiveness, with less systemic activity, than FP or BUD.

Ciclesonide in the Management of Asthma - Sage Journals

Ciclesonide is a novel inhaled corticosteroid (ICSs) approved in most countries for the management of persistent asthma.

In clinical trials to date, ciclesonide showed similar efficacy as compared with fine-particle ICSs, such as fluticasone and budesonide (MMAD ~3 ...

Full article: Ciclesonide for the treatment of asthma

Results with once-daily ciclesonide are similar to those with twice-daily budesonide or fluticasone. At the dosages used in clinical trials, ...

Ciclesonide versus other inhaled corticosteroids for chronic asthma ...

Hiremath, Comparison of once daily ciclesonide 160 µg versus twice daily fluticasone propionate 88 µg in children with moderate to severe asthma, European ...

15 Citations · Ciclesonide versus other inhaled corticosteroids for chronic asthma in children. · Efficacy and safety of high-dose ciclesonide for the treatment ...

are we ignoring the potential advantages of ciclesonide? - Nature

Drug adherence was higher in the ciclesonide group (76.0% vs. 58.7%, P=0.03) than in the budesonide group. The results of this study show that ...

Efficacy of Inhaled Ciclesonide for Outpatient Treatment of ...

Importance Systemic corticosteroids are commonly used in treating severe COVID-19. However, the role of inhaled corticosteroids in the treatment ...

Assessment of the Long-term Safety of Inhaled Ciclesonide on ...

Mean differences from placebo (5.75 cm/year) in growth velocity over the double-blind treatment period were −0.02 cm/year for ciclesonide 40 μg ...

Ciclesonide versus other inhaled corticosteroids for chronic asthma ...

The quality of evidence was judged 'low' for the outcomes asthma symptoms and adverse events and 'very low' for the outcome exacerbations for ciclesonide versus ...